FDCDDQ
EDIT icon

Federation des caisses Desjardins du Quebec’s Editas Medicine EDIT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.45K Hold
2,300
– – ﹤0.01% 2501
2026
Q1 		$5.68K Sell
2,300
-3,000
-57% -$6.35K ﹤0.01% 2466
2025
Q4 		$10.9K Sell
5,300
-200
-4% -$577 ﹤0.01% 2229
2025
Q3 		$19.1K Hold
5,500
– – ﹤0.01% 2058
2025
Q2 		$12.1K Hold
5,500
– – ﹤0.01% 1967
2025
Q1 		$6.38K Buy
5,500
+5,000
+1,000% +$7.36K ﹤0.01% 2104
2024
Q4 		$635 Sell
500
-50
-9% -$127 ﹤0.01% 2371
2024
Q3 		$1.88K Buy
550
+50
+10% +$218 ﹤0.01% 2231
2024
Q2 		$2.33K Hold
500
– – ﹤0.01% 2088
2024
Q1 		$3.71K Sell
500
-200
-29% -$1.66K ﹤0.01% 2020
2023
Q4 		$7.09K Hold
700
– – ﹤0.01% 1835
2023
Q3 		$5.46K Hold
700
– – ﹤0.01% 1895
2023
Q2 		$5.76K Hold
700
– – ﹤0.01% 1879
2023
Q1 		$5.08K Hold
700
– – ﹤0.01% 1905
2022
Q4 		$6.21K Hold
700
– – ﹤0.01% 1990
2022
Q3 		$8.57K Sell
700
-300
-30% -$4.67K ﹤0.01% 1951
2022
Q2 		$11.8K Sell
1,000
-100
-9% -$1.34K ﹤0.01% 1903
2022
Q1 		$20.9K Hold
1,100
– – ﹤0.01% 1809
2021
Q4 		$29.2K Sell
1,100
-200
-15% -$6.88K ﹤0.01% 1729
2021
Q3 		$53.4K Buy
1,300
+50
+4% +$2.74K ﹤0.01% 1586
2021
Q2 		$70.8K Sell
1,250
-335
-21% -$12.4K ﹤0.01% 1503
2021
Q1 		$66.6K Buy
1,585
+565
+55% +$32.2K ﹤0.01% 1458
2020
Q4 		$71.5K Buy
1,020
+820
+410% +$33.7K ﹤0.01% 1379
2020
Q3 		$5.61K Sell
200
-100
-33% -$3.26K ﹤0.01% 1835
2020
Q2 		$8.87K Hold
300
– – ﹤0.01% 1671
2020
Q1 		$5.95K Hold
300
– – ﹤0.01% 1782
2019
Q4 		$8.88K Buy
300
+100
+50% +$2.5K ﹤0.01% 1916
2019
Q3 		$4.55K Hold
200
– – ﹤0.01% 1980
2019
Q2 		$4.95K Buy
+200
New +$4.77K ﹤0.01% 1989

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's EDIT Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Editas Medicine (EDIT) position steady in Q2 2026 at 2,300 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Federation des caisses Desjardins du Quebec first reported a position in EDIT in Q2 2019 and has held it in 29 quarters since. The position peaked at $71.5K in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 2,300 shares of Editas Medicine worth $7.45K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2501 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Editas Medicine in Q2 2019 and has held it in 29 quarters since.
  • Federation des caisses Desjardins du Quebec's Editas Medicine position peaked at $71.5K in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.